Filed: 5/14/2026ACC: 0000919574-26-003017
📋 What this filing means
CAXTON CORP filed this quarterly 13F‑HR report disclosing 7 equity positions with a total reported market value of $4.02M. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
7
Positions
$4.02M
Total AUM (reported)
106.02K
Total Shares
Allocation by class
GOLD SHS$3.28M81.5%
CL B NEW$348.3K8.7%
COM$284.0K7.1%
COM NEW$112.0K2.8%
Portfolio Concentration
Top 3$3.79M94.2%
4–10$234.1K5.8%
Top 3 weight
94.2%
Top 10 weight
100.0%
Voting Authority Distribution
Total shares with voting rights: 106.02K
Sole
Full voting authority
106.02K
shares
% of voting shares100.0%
Shared
Joint voting authority
0.00
shares
% of voting shares0.0%
None
No voting authority
0.00
shares
% of voting shares0.0%
Investment Discretion (by position count)
Sole7
Shared0
Other0
Dominant voting typeSole · 100.0% of voting shares
Institutional Holdings7
Rows:
SPDR GOLD TR
SOLEShares7.62K
TypeSH
Market value$3.28M
81.50%
Sole
7.62K
Shared
0.00
None
0.00
BERKSHIRE HATHAWAY INC DEL
SOLEShares727.00
TypeSH
Market value$348.3K
8.66%
Sole
727.00
Shared
0.00
None
0.00
KYVERNA THERAPEUTICS INC
SOLEShares18.77K
TypeSH
Market value$162.0K
4.03%
Sole
18.77K
Shared
0.00
None
0.00
LEXEO THERAPEUTICS INC
SOLEShares13.94K
TypeSH
Market value$80.0K
1.99%
Sole
13.94K
Shared
0.00
None
0.00
X4 PHARMACEUTICALS INC
SOLEShares15.56K
TypeSH
Market value$64.2K
1.60%
Sole
15.56K
Shared
0.00
None
0.00
INHIBIKASE THERAPEUTICS INC
SOLEShares28.45K
TypeSH
Market value$47.8K
1.19%
Sole
28.45K
Shared
0.00
None
0.00
ALX ONCOLOGY HLDGS INC
SOLEShares20.95K
TypeSH
Market value$42.0K
1.04%
Sole
20.95K
Shared
0.00
None
0.00
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
SPDR GOLD TRSOLE | GOLD SHS | 7.62K | SH | $3.28M 81.50% | 7.62K | 0.00 | 0.00 |
BERKSHIRE HATHAWAY INC DELSOLE | CL B NEW | 727.00 | SH | $348.3K 8.66% | 727.00 | 0.00 | 0.00 |
KYVERNA THERAPEUTICS INCSOLE | COM | 18.77K | SH | $162.0K 4.03% | 18.77K | 0.00 | 0.00 |
LEXEO THERAPEUTICS INCSOLE | COM | 13.94K | SH | $80.0K 1.99% | 13.94K | 0.00 | 0.00 |
X4 PHARMACEUTICALS INCSOLE | COM NEW | 15.56K | SH | $64.2K 1.60% | 15.56K | 0.00 | 0.00 |
INHIBIKASE THERAPEUTICS INCSOLE | COM NEW | 28.45K | SH | $47.8K 1.19% | 28.45K | 0.00 | 0.00 |
ALX ONCOLOGY HLDGS INCSOLE | COM | 20.95K | SH | $42.0K 1.04% | 20.95K | 0.00 | 0.00 |